Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Did CVS Group PLC LSE:CVSG Rise 0.77% Amid a more positive tone across UK-listed veterinary services shares?

CVS Group PLC — LSE:CVSG closed 0.77% higher on14 September 2026, with the shares at 1,305.00p after a gain of 10.00p on the day.

Ishan Mudgal | 14 September 2026

Why Did Hikma Pharmaceuticals PLC LSE:HIK Rise 1.50% Amid a more positive tone across UK-listed pharmaceutical shares?

Hikma Pharmaceuticals PLC — LSE:HIK closed 1.50% higher on14 September 2026, with the shares at 1,554.00p after a gain of 23.00p on the day.

Ishan Mudgal | 14 September 2026

LSE:PXS Surges 14.29%: Could Provexis’ Fruitflow Strategy Unlock a Major Re-Rating?

Provexis plc is back on the radar afterLSE:PXS gained 14.29% on 14 September 2026, putting the small-cap healthcare company among the notable percentage movers in the London market.

Ankur Sharma | 14 September 2026

ImmuPharma Stock in Focus: LSE:IMM Gains 13.75% as Drug Development Pipeline Advances

ImmuPharma plc has become a notable small-cap healthcare stock afterLSE:IMM rose 13.75% on 14 September 2026.

Ankur Sharma | 14 September 2026

Verici Dx Shares Jump 11.11% as Investors Watch Kidney Transplant Diagnostics Growth

Verici Dx is attracting attention because its investment story is shifting from scientific development towardcommercial execution. That distinction is important for a small-cap healthcare company: investors are increasingly looking for evidence that validated technology can be converted into repeat testing revenue, wider clinical adoption …

Ankur Sharma | 14 September 2026

Why Thalia Therapeutics Shares Are Rising Today: miRisten and RNA Drug Pipeline in Focus

Thalia Therapeutics has become a very different company from the business investors knew under its previous identity.

Ankur Sharma | 14 September 2026

Top FTSE AIM All-Share Digital Healthcare Stocks for September 2026: Craneware, Cambridge Cognition and Kooth to Watch

Health systems on both sides of the Atlantic are under sustained pressure to do more with constrained budgets, and technology is central to how they respond. In the United States, hospitals are focused on revenue integrity, cost recovery and the economics of drug pricing; …

Divya Sood | 14 September 2026

Top FTSE 250 Manufacturing, Insurance & Biotech Stocks for September 2026: Volution (FAN), Lancashire (LRE) and Oxford Nanopore (ONT)

The FTSE 250 spans structurally growing manufacturers, specialty financial businesses and frontier-technology companies. These respond to very different forces — building regulation and theDemandfor cleaner indoor air, insurance-pricing cycles, and the adoption of new scientific tools — making theindexa way to assemble genuinely diversified …

Divya Sood | 14 September 2026

Top FTSE 250 Consumer & Healthcare Stocks for September 2026: Dunelm (DNLM), WH Smith (SMWH) and Oxford BioMedica (OXB)

The FTSE 250 rewards investors willing to look beyond the mega-caps for businesses with clearer, more specific stories. Consumer-facing retailers and life-sciences companies both feature prominently in the index, and together they capture two of the defining forces in the UKEquitymarket: the health of …

Divya Sood | 14 September 2026

LSE:CTHT Stock Under Pressure as Healthcare Markets and NAV Discount Take Centre Stage

CT Healthcare Trust is attracting attention because the stock is moving lower even though its underlying portfolio has demonstrated relative resilience against a difficult global healthcare backdrop.

Ankur Sharma | 11 September 2026
Support

Hi! How can we help you today?

Loading…